Afirma thyroid testing FY26 task order for fargo VA HCS
Active Awarded Last action
- Contract number
- 36C26326N0390
- Awardee
-
Veracyte, Inc. UEI JS7GBP6LCMN6
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $85,000
Award facts
- Contract value 100% obligated
- $85,000.00 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a delivery order valued at $85,000 to Veracyte, Inc. for Afirma thyroid testing services supporting the Fargo VA Health Care System. This firm fixed-price delivery order, issued on May 1, 2026, is scheduled for completion by April 30, 2027. The award carries no small business set-aside designation and reflects the proprietary and specialized nature of Veracyte's genomic diagnostic capabilities. The work will be performed at Veracyte's headquarters in South San Francisco, California.
This delivery order is issued under a larger $2 million indefinite delivery vehicle that VISN 23 maintains with Veracyte through April 30, 2028, for reference laboratory services including thyroid biopsy testing and specialty genomic testing across VA facilities in northern and central California. Veracyte, a leading medical diagnostic company specializing in advanced genomic testing for precision medicine applications, holds multiple IDV and blanket purchase agreements across the VA system, Defense Health Agency, and Indian Health Service. The Afirma Genomic Sequencing Classifier referenced in this task order analyzes gene expression patterns in thyroid nodules to assess malignancy risk and support clinical decision-making for thyroid cancer care within the VA system.
Quick answers
Who was awarded contract 36C26326N0390?
36C26326N0390 was awarded to Veracyte, Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on May 1, 2026.
How much is contract 36C26326N0390 worth?
The government has obligated $85,000 on 36C26326N0390.
Is contract 36C26326N0390 an order under another contract?
Yes. 36C26326N0390 is a delivery order under 36C26323D0087, an indefinite delivery contract.
Was contract 36C26326N0390 competed?
The extent of competition for 36C26326N0390 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award